Terns Pharmaceuticals Inc (TERN) — Net Asset Momentum
Terns Pharmaceuticals Inc (TERN) recorded a net asset momentum of 35.4% as of December 2024, with net assets of $345.87 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see market cap of Terns Pharmaceuticals Inc.
YoY Momentum
Current Net Assets
Years of Data
Country
Terns Pharmaceuticals Inc Net Asset Momentum (2018–2024)
This chart tracks Terns Pharmaceuticals Inc's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is +35.4%, with net assets of $345.87 Million USD as of December 2024. Check Terns Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Net Asset History for Terns Pharmaceuticals Inc (2018–2024)
The table below shows the complete annual net asset history for Terns Pharmaceuticals Inc from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Terns Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $345.87 Million | $363.93 Million | $18.06 Million | ▲ +35.4% |
| 2023 | $255.37 Million | $268.52 Million | $13.15 Million | ▼ -7.8% |
| 2022 | $276.94 Million | $287.03 Million | $10.08 Million | ▲ +72.8% |
| 2021 | $160.30 Million | $168.07 Million | $7.77 Million | ▲ +133.7% |
| 2020 | $68.59 Million | $92.29 Million | $23.70 Million | ▲ +274.3% |
| 2019 | $18.32 Million | $23.90 Million | $5.58 Million | ▼ -74.6% |
| 2018 | $72.23 Million | $89.07 Million | $16.84 Million | — |